The November 1, 2017 edition of ISMP QuarterWatch, a publication from the Institute for Safe Medication Practices, reports that a so-called “drug safety signal” has been detected recently for Entresto as regards hypotension being a serious side effect which warrants more attention — and, perhaps, and an increased warning. Relying upon “New data … [Read more...]